PM360
AUGUST 24, 2023
Today’s workforce includes Traditionalists (born 1927-1945), Boomers (1946-1964), Gen X (1965-1980), Millennials (1981-1996), and Gen Z (1997-2015). We have in front of us a unique opportunity to not only appreciate but harness the power of generational diversity as a competitive advantage.
Impetus Digital
MARCH 15, 2024
Increased competition and evolving standard of care New competitors are entering the market at a rapid pace, and competition is intensifying. This competitive intensity tends to focus on smaller patient populations with multiple treatment options (1,2). However, with rapid growth comes growing pains.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
DECEMBER 15, 2022
Healthcare Provider (HCP) marketing. Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media.
Impetus Digital
JANUARY 3, 2023
Healthcare Provider (HCP) Marketing. Back in 2015, the influencer-of-influencers, Kim Kardashian, was slammed for failing to mention the potential side effects of an anti-nausea drug, leading to the US FDA getting involved. Still, many pharma and medical marketers have been reluctant to engage with HCPs on social media.
Clarivate
APRIL 24, 2023
After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.
Referral MD
MAY 4, 2022
It seeks to optimize the way we establish and nurture meaningful and sustainable relationships in efforts to enhance patient experience, improve population health, reduce costs and improve the work life of healthcare providers – ultimately leading to increased trust in and loyalty to the organization. Enhance patient experience.
Pharmaceutical Technology
SEPTEMBER 26, 2022
Strong competition limits Sandoz's growth. Sandoz has faced and may in the future face strong competition from other generic and biosimilar pharmaceutical companies, which aggressively compete for market share, including through significant price competition. stake in their consumer healthcare joint venture for $13bn.
Expert insights. Personalized for you.
98 
Let's personalize your content